Ian Dittmer

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

Anders Åsberg, Atul Humar, Alan G. Jardine et al. · American Journal of Transplantation · 2009 · 182 citations

Translational Medicine, Transplantation, Solid Organ Transplantation +5

Organ Trafficking and Transplant Tourism

Gabriel M. Danovitch, Jeremy R. Chapman, Alexander Morgan Capron et al. · Transplantation · 2013 · 105 citations

Human Migration, Organ Donation, Organ Procurement +15

High bicarbonate dialysate in haemodialysis patients: effects on acidosis and nutritional status

Alistair J.K. Williams, Ian Dittmer, A. McArley et al. · Nephrology Dialysis Transplantation · 1997 · 99 citations